Dr Michael A Skinner

Publications


Journals

  • Bridge SH; Sharpe SA; Dennis MJ; Dowall SD; Getty B; Anson DS; Skinner MA; Stewart JP; et alBlanchard TJ. (2011). Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles. Virol J. 8:429. DOI.
  • Jeshtadi A; Burgos P; Stubbs CD; Parker AW; King LA; Skinner MA; Botchway SW. (Dec 2010). Interaction of poxvirus intracellular mature virion proteins with the TPR domain of kinesin light chain in live infected cells revealed by two-photon-induced fluorescence resonance energy transfer fluorescence lifetime imaging microscopy. J Virol. 84:12886-12894. DOI.
  • Bridge S; Sharpe S; Dennis M; Dowall S; Getty B; Skinner M; Hahn B; Stewart J; et alBlanchard T. (1 Apr 2010). HIV-neutralising response to recombinant, cross-clade, adjuvanted, virus-like particle-forming vaccine candidates. HIV MEDICINE. 11:40-40.
  • Skinner MA; Laidlaw SM. (2009). Advances in fowlpox vaccination. CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources. 4:1-10.
  • Guzman E; Taylor G; Charleston B; Skinner MA; Ellis SA. (Mar 2008). An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. J Gen Virol. 89:667-675. DOI.
  • Chaudhry Y; Skinner MA; Goodfellow IG. (Aug 2007). Recovery of genetically defined murine norovirus in tissue culture by using a fowlpox virus expressing T7 RNA polymerase. J Gen Virol. 88:2091-2100. DOI.
  • Childs K; Stock N; Ross C; Andrejeva J; Hilton L; Skinner M; Randall R; Goodbourn S. (1 Mar 2007). mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. VIROLOGY. 359:190-200. Author weblink DOI.
  • Jarmin SA; Manvell R; Gough RE; Laidlaw SM; Skinner MA. (Dec 2006). Retention of 1.2 kbp of 'novel' genomic sequence in two European field isolates and some vaccine strains of Fowlpox virus extends open reading frame fpv241. J Gen Virol. 87:3545-3549. DOI.
  • Imoukhuede EB; Berthoud T; Milligan P; Bojang K; Ismaili J; Keating S; Nwakanma D; Keita S; et alNjie F; Sowe M; Todryk S; Laidlaw SM; Skinner MA; Lang T; Gilbert S; Greenwood BM; Hill AV. (30 Oct 2006). Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men. Vaccine. 24:6526-6533. DOI.
  • Jarmin S; Manvell R; Gough RE; Laidlaw SM; Skinner MA. (Aug 2006). Avipoxvirus phylogenetics: identification of a PCR length polymorphism that discriminates between the two major clades. J Gen Virol. 87:2191-2201. DOI.
  • Cottingham MG; van Maurik A; Zago M; Newton AT; Anderson RJ; Howard MK; Schneider J; Skinner MA. (Jul 2006). Different levels of immunogenicity of two strains of Fowlpox virus as recombinant vaccine vectors eliciting T-cell responses in heterologous prime-boost vaccination strategies. Clin Vaccine Immunol. 13:747-757. DOI.
  • Webster DP; Dunachie S; McConkey S; Poulton I; Moore AC; Walther M; Laidlaw SM; Peto T; et alSkinner MA; Gilbert SC; Hill AV. (5 Apr 2006). Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers. Vaccine. 24:3026-3034. DOI.
  • Jeshtadi A; Henriquet G; Laidlaw SM; Hot D; Zhang Y; Skinner MA. (Sep 2005). In vitro expression and analysis of secreted fowlpox virus CC chemokine-like proteins Fpv060, Fpv061, Fpv116 and Fpv121. Arch Virol. 150:1745-1762. DOI.
  • Webster DP; Dunachie S; Vuola JM; Berthoud T; Keating S; Laidlaw SM; McConkey SJ; Poulton I; et alAndrews L; Andersen RF; Bejon P; Butcher G; Sinden R; Skinner MA; Gilbert SC; Hill AV. (29 Mar 2005). Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. Proc Natl Acad Sci U S A. 102:4836-4841. DOI.
  • Skinner MA; Laidlaw SM; Eldaghayes I; Kaiser P; Cottingham MG. (Feb 2005). Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry. Expert Rev Vaccines. 4:63-76. DOI.
  • Moorthy VS; Imoukhuede EB; Keating S; Pinder M; Webster D; Skinner MA; Gilbert SC; Walraven G; et alHill AV. (15 Jun 2004). Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men. J Infect Dis. 189:2213-2219. DOI.
  • Anderson RJ; Hannan CM; Gilbert SC; Laidlaw SM; Sheu EG; Korten S; Sinden R; Butcher GA; et alSkinner MA; Hill AV. (1 Mar 2004). Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus. J Immunol. 172:3094-3100.
  • Laidlaw SM; Skinner MA. (Feb 2004). Comparison of the genome sequence of FP9, an attenuated, tissue culture-adapted European strain of Fowlpox virus, with those of virulent American and European viruses. J Gen Virol. 85:305-322.
  • Boulanger D; Green P; Jones B; Henriquet G; Hunt LG; Laidlaw SM; Monaghan P; Skinner MA. (Oct 2002). Identification and characterization of three immunodominant structural proteins of fowlpox virus. J Virol. 76:9844-9855.
  • Vázquez Blomquist D; Green P; Laidlaw SM; Skinner MA; Borrow P; Duarte CA. (2002). Induction of a strong HIV-specific CD8+ T cell response in mice using a fowlpox virus vector expressing an HIV-1 multi-CTL-epitope polypeptide. Viral Immunol. 15:337-356. DOI.
  • Kataria RS; Tiwari AK; Butchaiah G; Kataria JM; Skinner MA. (1 Oct 2001). Sequence analysis of the VP2 gene hypervariable region of infectious bursal disease viruses from India. AVIAN PATHOLOGY. 30:501-507. Author weblink.
  • Phenix KV; Wark K; Luke CJ; Skinner MA; Smyth JA; Mawhinney KA; Todd D. (30 Apr 2001). Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development. Vaccine. 19:3116-3123.
  • Brown M; Zhang Y; Dermine S; de Wynter EA; Hart C; Kitchener H; Stern PL; Skinner MA; et alStacey SN. (Oct 2000). Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity. Gene Ther. 7:1680-1689. DOI.
  • Das SC; Baron MD; Skinner MA; Barrett T. (Sep 2000). Improved technique for transient expression and negative strand virus rescue using fowlpox T7 recombinant virus in mammalian cells. J Virol Methods. 89:119-127.
  • Boulanger D; Smith T; Skinner MA. (Mar 2000). Morphogenesis and release of fowlpox virus. J Gen Virol. 81:675-687.
  • Brown M; Davies DH; Skinner MA; Bowen G; Hollingsworth SJ; Mufti GJ; Arrand JR; Stacey SN. (May 1999). Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors. Cancer Gene Ther. 6:238-245. DOI.
  • Eterradossi N; Arnauld C; Tekaia F; Toquin D; Le Coq H; Rivallan G; Guittet M; Domenech J; et alvan den Berg TP; Skinner MA. (1 Feb 1999). Antigenic and genetic relationships between European very virulent infectious bursal disease viruses and an early West African isolate. AVIAN PATHOLOGY. 28:36-46. Author weblink.
  • Laidlaw SM; Anwar MA; Thomas W; Green P; Shaw K; Skinner MA. (Aug 1998). Fowlpox virus encodes nonessential homologs of cellular alpha-SNAP, PC-1, and an orphan human homolog of a secreted nematode protein. J Virol. 72:6742-6751.
  • Pollitt E; Skinner MA; Heaphy S. (1998). Nucleotide sequence of the 4.3 kbp BamHI-N fragment of fowlpox virus FP9. Virus Genes. 17:5-9.
  • Boulanger D; Green P; Smith T; Czerny CP; Skinner MA. (Jan 1998). The 131-amino-acid repeat region of the essential 39-kilodalton core protein of fowlpox virus FP9, equivalent to vaccinia virus A4L protein, is nonessential and highly immunogenic. J Virol. 72:170-179.
  • Britton P; Green P; Kottier S; Mawditt KL; Penzes Z; Cavanagh D; Skinner MA. (May 1996). Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus. J Gen Virol. 77 ( Pt 5):963-967.
  • Brown MD; Skinner MA. (Jan 1996). Coding sequences of both genome segments of a European 'very virulent' infectious bursal disease virus. Virus Res. 40:1-15.
  • SKINNER MA. (1 Jun 1995). REPORT ON THE 1ST INTERNATIONAL-SYMPOSIUM ON INFECTIOUS BURSAL-DISEASE AND CHICKEN INFECTIOUS-ANEMIA. AVIAN PATHOLOGY. 24:359-362. Author weblink.
  • Bai J; Payne LN; Skinner MA. (Feb 1995). HPRS-103 (exogenous avian leukosis virus, subgroup J) has an env gene related to those of endogenous elements EAV-0 and E51 and an E element found previously only in sarcoma viruses. J Virol. 69:779-784.
  • Bai J; Howes K; Payne LN; Skinner MA. (Jan 1995). Sequence of host-range determinants in the env gene of a full-length, infectious proviral clone of exogenous avian leukosis virus HPRS-103 confirms that it represents a new subgroup (designated J). J Gen Virol. 76 ( Pt 1):181-187.
  • Li D; Green PF; Skinner MA; Jiang C; Ross N. (Dec 1994). Use of recombinant pp38 antigen of Marek's disease virus to identify serotype 1-specific antibodies in chicken sera by western blotting. J Virol Methods. 50:185-195.
  • Skinner MA; Moore JB; Binns MM; Smith GL; Boursnell ME. (Sep 1994). Deletion of fowlpox virus homologues of vaccinia virus genes between the 3 beta-hydroxysteroid dehydrogenase (A44L) and DNA ligase (A50R) genes. J Gen Virol. 75 ( Pt 9):2495-2498.
  • Qingzhong Y; Barrett T; Brown TD; Cook JK; Green P; Skinner MA; Cavanagh D. (May 1994). Protection against turkey rhinotracheitis pneumovirus (TRTV) induced by a fowlpox virus recombinant expressing the TRTV fusion glycoprotein (F). Vaccine. 12:569-573.
  • Brown MD; Green P; Skinner MA. (Mar 1994). VP2 sequences of recent European 'very virulent' isolates of infectious bursal disease virus are closely related to each other but are distinct from those of 'classical' strains. J Gen Virol. 75 ( Pt 3):675-680.
  • Somogyi P; Frazier J; Skinner MA. (Nov 1993). Fowlpox virus host range restriction: gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells. Virology. 197:439-444. DOI.
  • Almond JW; Stone D; Burke K; Skinner MA; Macadam AJ; Wood D; Ferguson M; Minor PD. (1993). Approaches to the construction of new candidate poliovirus type 3 vaccine strains. Dev Biol Stand. 78:161-169.
  • Mockett B; Binns MM; Boursnell ME; Skinner MA. (Oct 1992). Comparison of the locations of homologous fowlpox and vaccinia virus genes reveals major genome reorganization. J Gen Virol. 73 ( Pt 10):2661-2668.
  • Binns MM; Boursnell ME; Skinner MA. (Jul 1992). Gene translocations in poxviruses: the fowlpox virus thymidine kinase gene is flanked by 15 bp direct repeats and occupies the locus which in vaccinia virus is occupied by the ribonucleotide reductase large subunit gene. Virus Res. 24:161-172.
  • Skinner MA. (11 Nov 1991). Murine plasma cell antigen PC-1 has a region homologous to the active site of bovine intestinal 5'-nucleotide phosphodiesterase I (EC 3.1.4.1). Nucleic Acids Res. 19:6049.
  • Dingwall C; Ernberg I; Gait MJ; Green SM; Heaphy S; Karn J; Lowe AD; Singh M; et alSkinner MA. (Dec 1990). HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J. 9:4145-4153.
  • Heaphy S; Dingwall C; Ernberg I; Gait MJ; Green SM; Karn J; Lowe AD; Singh M; et alSkinner MA. (23 Feb 1990). HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell. 60:685-693.
  • Dingwall C; Ernberg I; Gait MJ; Green SM; Heaphy S; Karn J; Lowe AD; Singh M; et alSkinner MA; Valerio R. (Sep 1989). Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci U S A. 86:6925-6929.
  • Skinner MA; Racaniello VR; Dunn G; Cooper J; Minor PD; Almond JW. (20 May 1989). New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol. 207:379-392.
  • Westrop GD; Wareham KA; Evans DM; Dunn G; Minor PD; Magrath DI; Taffs F; Marsden S; et alSkinner MA; Schild GC. (Mar 1989). Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol. 63:1338-1344.
  • SCHMIDT I; SKINNER M; SIDDELL S. (1 Jan 1987). NUCLEOTIDE-SEQUENCE OF THE GENE ENCODING THE SURFACE PROJECTION GLYCOPROTEIN OF CORONAVIRUS MHV-JHM. JOURNAL OF GENERAL VIROLOGY. 68:47-56. Author weblink DOI.
  • Almond JW; Westrop GD; Wareham KA; Skinner MA; Evans DM; Magrath D; Schild GC; Minor PD. (1987). Studies on the genetic basis of attenuation of the Sabin type 3 poliovirus vaccine. Biochem Soc Symp. 53:85-90.
  • BROOK JD; SHAW DJ; HARLEY H; WALSH K; RETTIG WJ; SKINNER M; POVEY S; HARPER PS; et alGLASER T; JACKSON C; KENT R; HOUSMAN D. (1 Jan 1987). THE LOCALIZATION OF MARKERS RELATIVE TO THE CENTROMERE OF CHROMOSOME-19. CYTOGENETICS AND CELL GENETICS. 46:587-587. Author weblink.
  • PFLEIDERER M; SKINNER MA; SIDDELL SG. (11 Aug 1986). CORONAVIRUS MHV-JHM - NUCLEOTIDE-SEQUENCE OF THE MESSENGER-RNA THAT ENCODES THE MEMBRANE-PROTEIN. NUCLEIC ACIDS RESEARCH. 14:6338-6338. Author weblink DOI.
  • SKINNER MA; SIDDELL SG. (1 Jan 1985). CODING SEQUENCE OF CORONAVIRUS MHV-JHM MESSENGER RNA-4. JOURNAL OF GENERAL VIROLOGY. 66:593-596. Author weblink DOI.
  • SKINNER MA; EBNER D; SIDDELL SG. (1 Jan 1985). CORONAVIRUS MHV-JHM MESSENGER-RNA 5 HAS A SEQUENCE ARRANGEMENT WHICH POTENTIALLY ALLOWS TRANSLATION OF A 2ND, DOWNSTREAM OPEN READING FRAME. JOURNAL OF GENERAL VIROLOGY. 66:581-592. Author weblink DOI.
  • SKINNER MA; SIDDELL SG. (1 Jan 1983). CORONAVIRUS JHM - NUCLEOTIDE-SEQUENCE OF THE MESSENGER-RNA THAT ENCODES NUCLEOCAPSID PROTEIN. NUCLEIC ACIDS RESEARCH. 11:5045-5054. Author weblink DOI.
  • SPAAN W; DELIUS H; SKINNER M; ARMSTRONG J; ROTTIER P; SMEEKENS S; VANDERZEIJST BAM; SIDDELL SG. (1 Jan 1983). CORONAVIRUS MESSENGER-RNA SYNTHESIS INVOLVES FUSION OF NON-CONTIGUOUS SEQUENCES. EMBO JOURNAL. 2:1839-1844. Author weblink.
  • SKINNER MA; SIDDELL SG. (1 Jan 1983). SEQUENCE-ANALYSIS OF MOUSE HEPATITIS-VIRUS JHM MESSENGER RNA7 - EVIDENCE FOR AN UNUSUAL RNA SPLICING EVENT. ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY. 255:184-185. Author weblink.
  • SKINNER MA; COOPER RA. (1 Jan 1982). AN ESCHERICHIA-COLI MUTANT DEFECTIVE IN THE NAD-DEPENDENT SUCCINATE SEMI-ALDEHYDE DEHYDROGENASE. ARCHIVES OF MICROBIOLOGY. 132:270-275. Author weblink DOI.
  • COOPER RA; SKINNER MA. (1 Jan 1980). CATABOLISM OF 3-HYDROXYPHENYLACETATE AND 4-HYDROXYPHENYLACETATE BY THE 3,4-DIHYDROXYPHENYLACETATE PATHWAY IN ESCHERICHIA-COLI. JOURNAL OF BACTERIOLOGY. 143:302-306. Author weblink.

Chapters in books

  • Skinner MA; Laidlaw SM. Recombinant Avipoxviruses. In Vaccinology: Principles and Practice. Morrow JH (ed); Schmidt C (ed); Sheikh N (ed); Davies H (ed). Wiley-Blackwell (17 Aug 2012).
  • Skinner MA; Buller RM; Damon IK; Lefkowiz EJ; McFadden, G; McInnes, C J; Mercer AA; Moyer, R W; et alUpton C. Family: Poxviridae. In Virus Taxonomy - Ninth Report of the International Committee on Taxonomy of Viruses. King AM (ed); Lefkowitz E (ed); Adams MJ (ed); Carstens EB (ed). Elsevier Science Ltd (15 Sep 2011).
  • Skinner MA. Fowlpox virus and other avipoxviruses. In Encyclopedia of Virology. Third. Mahy BWJ (ed); Van Regenmortel MHV (ed). Academic Press (Mar 2008).
  • Smith GL; Beard P; Skinner MA. Poxviruses. In Encyclopedia of Virology. Third. Mahy BWJ (ed); Van Regenmortel MHV (ed). Academic Press (Mar 2008).
  • Schat KA; Skinner MA. Avian Immunosuppressive Diseases and Immune Evasion. In Avian Immunology. 301-324. Davison F (ed); Kaspers B (ed); Schat KA (ed). Elsevier (Jan 2008).
  • Skinner MA. Poxviridae. In Poultry Diseases. 6th. Pattison M (ed); McMullin P (ed); Bradbury J (ed); Alexander D (ed). Elsevier (Dec 2007).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook